{"docid":"VWS-WOO-06-200434","collapsed":true,"count":1,"unchecked":0,"snapshots_total":8,"versions":[{"archive_id":"folder_import_6244_6a117900efa426db87e9ffc2ead3cfac","bestandsnaam":"VWS-WOO-06-200434.pdf","created_date":"2025-09-08 18:22:52","last_seen":"2025-09-08 18:22:52","from_file":"folder_import","bron":"/volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-06-200434.pdf","snippet":"200434    CE IvD    Celltrion Sampinute™  COVID-19 Antigen MIA  User Manual    (OO HEALTHCARE  O@CELLTRION™    \f200434    Table of Contents    Product Introduction  Intended Use    Principle    Produc","digest":"0a3e4e57a9dc","dupes":8,"date_to":"2025-09-08 18:22:52","date_from":"2025-02-18 12:18:18","unchecked":false}],"raw":[{"archive_id":"folder_import_6244_6a117900efa426db87e9ffc2ead3cfac","bestandsnaam":"VWS-WOO-06-200434.pdf","created_date":"2025-09-08 18:22:52","last_seen":"2025-09-08 18:22:52","from_file":"folder_import","bron":"/volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-06-200434.pdf","snippet":"200434    CE IvD    Celltrion Sampinute™  COVID-19 Antigen MIA  User Manual    (OO HEALTHCARE  O@CELLTRION™    \f200434    Table of Contents    Product Introduction  Intended Use    Principle    Produc","digest":"0a3e4e57a9dc"},{"archive_id":"VWS-WOO-3561075-1045762-pdo-1f026c98-596f-6fac-9ca6-65673e0af118.zip_2642","bestandsnaam":"VWS-WOO-06-200434.pdf","created_date":"2025-09-04 17:09:02","last_seen":"2025-09-04 17:09:02","from_file":"VWS-WOO-3561075-1045762-pdo-1f026c98-596f-6fac-9ca6-65673e0af118.zip","bron":"../../archieven_files/VWS-WOO-3561075-1045762-pdo-1f026c98-596f-6fac-9ca6-65673e0af118.zip","snippet":"200434    CE IvD    Celltrion Sampinute™  COVID-19 Antigen MIA  User Manual    (OO HEALTHCARE  O@CELLTRION™    \f200434    Table of Contents    Product Introduction  Intended Use    Principle    Produc","digest":"0a3e4e57a9dc"},{"archive_id":"VWS-WOO-3561075-1045762-pdo-1f019e39-86a8-6448-a66f-8b11f5f0b699.zip_2642","bestandsnaam":"VWS-WOO-06-200434.pdf","created_date":"2025-09-04 17:07:43","last_seen":"2025-09-04 17:07:43","from_file":"VWS-WOO-3561075-1045762-pdo-1f019e39-86a8-6448-a66f-8b11f5f0b699.zip","bron":"../../archieven_files/VWS-WOO-3561075-1045762-pdo-1f019e39-86a8-6448-a66f-8b11f5f0b699.zip","snippet":"200434    CE IvD    Celltrion Sampinute™  COVID-19 Antigen MIA  User Manual    (OO HEALTHCARE  O@CELLTRION™    \f200434    Table of Contents    Product Introduction  Intended Use    Principle    Produc","digest":"0a3e4e57a9dc"},{"archive_id":"351450","bestandsnaam":"VWS-WOO-06-200434.pdf","created_date":"2025-03-18 09:30:26","last_seen":"2025-03-18 09:30:26","from_file":"2024.075-VWS-WOO-3561075-1045762-pdo.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\2024.075-VWS-WOO-3561075-1045762-pdo.zip","snippet":"CEIvD\nCelltrion Sampinute™\nCOVID-19 Antigen MIA\nUser Manual\n(OO HEALTHCARE\nO@CELLTRION™200434\nTable ofContents200434\nProduct Introduction\nIntended Use\nPrinciple\nProduct Description\nPrincipal Ingredien","digest":"0a3e4e57a9dc"},{"archive_id":"264620","bestandsnaam":"VWS-WOO-06-200434.pdf","created_date":"2025-02-27 09:25:05","last_seen":"2025-02-27 09:25:05","from_file":"2023.031-VWS-WOO-3561075-1045762-pdo.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\2023.031-VWS-WOO-3561075-1045762-pdo.zip","snippet":"CEIvD\nCelltrion Sampinute™\nCOVID-19 Antigen MIA\nUser Manual\n(OO HEALTHCARE\nO@CELLTRION™200434\nTable ofContents200434\nProduct Introduction\nIntended Use\nPrinciple\nProduct Description\nPrincipal Ingredien","digest":"0a3e4e57a9dc"},{"archive_id":"189506","bestandsnaam":"VWS-WOO-06-200434-1._Celltrion_Sampinute____COVID-19_Antigen_MIA_IFU.pdf","created_date":"2025-02-18 12:36:31","last_seen":"2025-02-18 12:36:31","from_file":"besluit-3561075-1045762-pdo-6f22100bd532202fbf0d026fb84fa485bc843b08661737385d886dcb54aeb3dd.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\besluit-3561075-1045762-pdo-6f22100bd532202fbf0d026fb84fa485bc843b08661737385d886dcb54aeb3dd.zip","snippet":"CEIvD\nCelltrion Sampinute™\nCOVID-19 Antigen MIA\nUser Manual\n(OO HEALTHCARE\nO@CELLTRION™200434\nTable ofContents200434\nProduct Introduction\nIntended Use\nPrinciple\nProduct Description\nPrincipal Ingredien","digest":"0a3e4e57a9dc"},{"archive_id":"150935","bestandsnaam":"VWS-WOO-06-200434.pdf","created_date":"2025-02-18 12:18:19","last_seen":"2025-02-18 12:18:19","from_file":"besluit-3561075-1045762-pdo-6f22100bd532202fbf0d026fb84fa485bc843b08661737385d886dcb54aeb3dd.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\besluit-3561075-1045762-pdo-6f22100bd532202fbf0d026fb84fa485bc843b08661737385d886dcb54aeb3dd.zip","snippet":"200434    CE IvD    Celltrion Sampinute™  COVID-19 Antigen MIA  User Manual    (OO HEALTHCARE  O@CELLTRION™    \f200434    Table of Contents    Product Introduction  Intended Use    Principle    Produc","digest":"0a3e4e57a9dc"},{"archive_id":"139008","bestandsnaam":"VWS-WOO-06-200434.pdf","created_date":"2025-02-18 12:18:18","last_seen":"2025-02-18 12:18:18","from_file":"VWS-WOO-3561075-1045762-pdo-6f22100bd532202fbf0d026fb84fa485bc843b08661737385d886dcb54aeb3dd.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\VWS-WOO-3561075-1045762-pdo-6f22100bd532202fbf0d026fb84fa485bc843b08661737385d886dcb54aeb3dd.zip","snippet":"CEIvD\nCelltrion Sampinute™\nCOVID-19 Antigen MIA\nUser Manual\n(OO HEALTHCARE\nO@CELLTRION™200434\nTable ofContents200434\nProduct Introduction\nIntended Use\nPrinciple\nProduct Description\nPrincipal Ingredien","digest":"0a3e4e57a9dc"}],"filename":"1. Celltrion Sampinute™ COVID-19 Antigen MIA IFU.pdf","truncated":false,"elapsed_ms":15}